AzTrials
AzTrials

HemodialysisNCT07842939

Pre-Cannulation Ultrasound Vascular Mapping Combined With Handgrip Exercise and Local Cryotherapy in Hemodialysis Patients With Difficult Cannulation

A study testing Pre-Cannulation Ultrasound Vascular Mapping, Handgrip Exercise and Local Cryotherapy in people with Hemodialysis and Difficult Vascular Access Cannulation, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot randomized controlled trial evaluated a multicomponent intervention for adult maintenance hemodialysis patients with difficult vascular access cannulation. Participants were randomly assigned to an intervention group or a usual-care control group. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Pre-Cannulation Ultrasound Vascular Mapping, Handgrip Exercise and Local Cryotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
69 participants
Where
1 siteTaiwan
Study dates
24 Dec 2025to 31 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 20 years or older.
  • Receiving maintenance hemodialysis for at least 3 months.
  • Having an arteriovenous fistula or arteriovenous graft for hemodialysis vascular access.
  • Having difficult vascular access cannulation, defined as requiring two or more cannulation attempts during at least one of the two most recent hemodialysis sessions.
  • Able to understand the study information and provide written informed consent.

Who cannot join

  • Newly created vascular access that had not yet matured or was not clinically stable for routine cannulation.
  • Acute or clinically unstable medical condition.
  • Cognitive or language impairment that prevented completion of the study questionnaires.
  • Contraindication to local cryotherapy or handgrip exercise.
  • Previous participation in this study or in the study pretest.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City

Other trials in Taiwan

About this study

Official title: Effects of Pre-Cannulation Ultrasound Vascular Mapping Combined With Handgrip Exercise and Local Cryotherapy on Pain, Anxiety, Comfort, Satisfaction, and Cannulation Success in Hemodialysis Patients With Difficult Cannulation: A Pilot Randomized Controlled Trial

This pilot randomized controlled trial evaluated a multicomponent intervention for adult maintenance hemodialysis patients with difficult vascular access cannulation. Participants were randomly assigned to an intervention group or a usual-care control group. The intervention included pre-cannulation ultrasound vascular mapping, handgrip exercise, and local cryotherapy before vascular access cannulation. The study assessed visual analog scale pain, first-attempt cannulation success, perceived pain, anxiety, comfort, and overall care satisfaction. Participants in the intervention group also evaluated the acceptability of the intervention.

Being tested
Pre-Cannulation Ultrasound Vascular Mapping, Handgrip Exercise, Local Cryotherapy, Usual Care
Keywords
Ultrasound Vascular Mapping, Handgrip Exercise, Local Cryotherapy, Cannulation Pain, First-Attempt Cannulation Success

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pre-Cannulation Ultrasound Vascular MappingOther

    Pre-cannulation ultrasound vascular mapping was performed before vascular access cannulation to assess vessel course, depth, blood flow, and suitable cannulation areas. The vascular map was provided as a reference for the cannulating nurse when selecting the cannulation site. Routine visual inspection and palpation were also performed before cannulation.

  • Handgrip ExerciseBehavioural

    Participants performed handgrip exercise before vascular access cannulation as part of the multicomponent intervention.

  • Local CryotherapyOther

    Local cryotherapy was applied before vascular access cannulation as part of the multicomponent intervention.

  • Usual CareOther

    Participants in the control group received usual care, including routine visual inspection and palpation of the vascular access before cannulation. They did not receive pre-cannulation ultrasound vascular mapping, handgrip exercise, or local cryotherapy.

Study groups in NCT07842939
Study groupRoleWhat they receive
Intervention GroupExperimentalParticipants in the intervention group received pre-cannulation ultrasound vascular mapping, handgrip exercise, and local cryotherapy in addition to routine visual inspection and palpation before vascular access cannulation.
Receives: Other: Pre-Cannulation Ultrasound Vascular Mapping; Behavioral: Handgrip Exercise; Other: Local Cryotherapy
Control GroupActive comparatorParticipants in the control group received usual care, including routine visual inspection and palpation before vascular access cannulation, without the multicomponent intervention.
Receives: Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VAS Pain Score

    Pain intensity was assessed using a 0-10 visual analog scale (VAS), with higher scores indicating greater pain. VAS pain was measured before vascular access cannulation and immediately after completion of arterial and venous needle insertion.

    Measured: Before cannulation and immediately after completion of arterial and venous needle insertion on the same hemodialysis session.

  2. First-Attempt Cannulation Success

    First-attempt cannulation success was defined as successful placement of both arterial and venous needles on the first attempt. If either needle required repeat cannulation and the total number of needle insertions exceeded two, the cannulation was classified as unsuccessful on the first attempt.

    Measured: During vascular access cannulation in the same hemodialysis session.

Secondary outcomes (4)
  1. Pain Perception Score

    Pain perception was assessed using a 5-item questionnaire. Each item was rated on a 4-point Likert scale, with a total score ranging from 5 to 20. Higher scores indicated greater pain perception. The scale was administered before vascular access cannulation and immediately after completion of arterial and venous needle insertion.

    Measured: Before cannulation and immediately after completion of arterial and venous needle insertion in the same hemodialysis session.

  2. Anxiety Perception Score

    Anxiety perception was assessed using a 5-item questionnaire. Each item was rated on a 4-point Likert scale, with a total score ranging from 5 to 20. Higher scores indicated greater anxiety perception. The scale was administered before vascular access cannulation and immediately after completion of arterial and venous needle insertion.

    Measured: Before cannulation and immediately after completion of arterial and venous needle insertion in the same hemodialysis session.

  3. Comfort Score

    Comfort was assessed using a 4-item questionnaire. Each item was rated on a 4-point Likert scale, with a total score ranging from 4 to 16. Higher scores indicated greater comfort. The scale was administered before vascular access cannulation and immediately after completion of arterial and venous needle insertion.

    Measured: Before cannulation and immediately after completion of arterial and venous needle insertion in the same hemodialysis session.

  4. Overall Care Satisfaction Score

    Overall care satisfaction was assessed using a 6-item questionnaire. Each item was rated on a 4-point Likert scale, with a total score ranging from 6 to 24. Higher scores indicated greater satisfaction with overall care. The scale was administered before vascular access cannulation and immediately after completion of arterial and venous needle insertion.

    Measured: Before cannulation and immediately after completion of arterial and venous needle insertion in the same hemodialysis session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2026
  2. Study start24 Dec 2025
  3. Primary completion31 Jul 2026
  4. Study completion31 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
69 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07842939
Sponsor's protocol ID
202501448B0
Status last verified
Sep 2026
First submitted
21 Sep 2026
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because data sharing was not included in the original study protocol or informed consent.

Questions about this trial

What is this clinical trial studying?

A study testing Pre-Cannulation Ultrasound Vascular Mapping, Handgrip Exercise and Local Cryotherapy in people with Hemodialysis and Difficult Vascular Access Cannulation, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VAS Pain Score (time frame: Before cannulation and immediately after completion of arterial and venous needle insertion on the same hemodialysis session.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07842939 | AzTrials